Johanna Mercier, Chief Commercial Officer of Gilead Sciences Inc, sold 29,357 shares, now owning 78,127. The company focuses on innovative medicines for various diseases. Recent insider trends show 10 sells and no buys.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing